Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.33 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.33 |
| ▸ | AIMP2 | Q13155 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 6/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.32 |
| ▸ | APLNR | P35414 | 1/20 | 0.32 |
| ▸ | CCR6 | P51684 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22134660 | 0.86 | TRPV1 (0.37) | CYP19A1NPC1RAB9ALTB4RLTB4R2 | |
| SCHEMBL25814574 | 0.76 | CYP19A1 (0.42) | CYP19A1NPC1RAB9ALTB4RLTB4R2 | |
| SCHEMBL22134628 | 0.71 | CYP19A1 (0.44) | CYP19A1NPC1RAB9AAIMP2TRPV1 | |
| SCHEMBL22134742 | 0.70 | TRPV1 (0.39) | CYP19A1NPC1RAB9ALTB4RLTB4R2 | |
| SCHEMBL25815137 | 0.70 | CYP19A1 (0.38) | CYP19A1NPC1RAB9AAIMP2TRPV1 | |
| SCHEMBL23024716 | 0.69 | CYP19A1 (0.46) | CYP19A1NPC1RAB9AAIMP2TRPV1 | |
| SCHEMBL20021532 | 0.67 | EPM2A (0.34) | CYP19A1NPC1RAB9ALTB4RLTB4R2 | |
| SCHEMBL21101055 | 0.66 | ALDH1A1 (0.47) | CYP19A1NPC1RAB9AAIMP2MAPT | |
| SCHEMBL9869995 | 0.65 | HRH3 (0.42) | CYP19A1NPC1RAB9AAIMP2MAPT | |
| SCHEMBL22134641 | 0.65 | TRPV1 (0.43) | CYP19A1NPC1RAB9AAIMP2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219919-A1 | LITHIUM EXTRACTION WITH CROWN ETHERS | ORCA HOLDINGS, LLC | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219919-A1 | LITHIUM EXTRACTION WITH CROWN ETHERS | LCLAT1, LCT, IGF2R | CYP19A1 4811/4885NPC1 583/4885RAB9A 2052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.